Ht-Logo-gigapixel-icon
Search
Close this search box.
Ht-Logo-gigapixel-icon
Search
Close this search box.
Thursday, November 21, 2024
Canada’s Politics and Government News Source Since 1989
Latest Paper
Thursday, November 21, 2024 | Latest Paper
Subscribe Now

TRENDING:

Nav Persaud

The NDP-backed pharmacare plan is a corporate handout as written

  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

The NDP-backed pharmacare plan is a corporate handout as written

  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.

The NDP-backed pharmacare plan is a corporate handout as written

Opinion | BY STEVE MORGAN, MATTHEW HERDER, NAV PERSAUD | September 9, 2024
  • The real problem with this signature legislation of the NDP-Liberal agreement is that it will not bring medicines within Canada’s publicly funded health system.
New Democratic Party leader Jagmeet Singh speaks with reporters in the House of Commons foyer before Question Period on June 3, 2024, about the upcoming vote on the government’s pharmacare bill.
It’s hard to square NDP Leader Jagmeet Singh’s concern over bowing to corporate interests with his party's support for such a pharmacare plan, write Steve Morgan, Matthew Herder, and Nav Persaud. The Hill Times photograph by Andrew Meade

Liberal-NDP deal promises nothing more than a pharmacare pantomime

  • NDP Leader Jagmeet Singh stepped over broken promises about pharmacare walking down the aisle to join Prime Minister Justin Trudeau in a confidence and
Opinion | BY NAV PERSAUD | March 31, 2022
NDP Leader Jagmeet Singh and Prime Minister Justin Trudeau have each got a lot of political mileage out of past pharmacare announcements. Last week's vague joint announcement continued the positive coverage, writes Nav Persaud. The Hill Times photographs by Sam Garcia and Andrew Meade

Liberal-NDP deal promises nothing more than a pharmacare pantomime

Opinion | BY NAV PERSAUD | March 31, 2022
  • NDP Leader Jagmeet Singh stepped over broken promises about pharmacare walking down the aisle to join Prime Minister Justin Trudeau in a confidence and

Liberal-NDP deal promises nothing more than a pharmacare pantomime

Opinion | BY NAV PERSAUD | March 31, 2022
  • NDP Leader Jagmeet Singh stepped over broken promises about pharmacare walking down the aisle to join Prime Minister Justin Trudeau in a confidence and
NDP Leader Jagmeet Singh and Prime Minister Justin Trudeau have each got a lot of political mileage out of past pharmacare announcements. Last week's vague joint announcement continued the positive coverage, writes Nav Persaud. The Hill Times photographs by Sam Garcia and Andrew Meade

Path to a stronger, more resilient Canada starts with equity

  • COVID-19 will not take a break this holiday season, so we must remain focused on slowing its spread and on addressing the undercurrent that
Opinion | BY NAV PERSAUD | December 28, 2021
While we focus on omicron’s rise, now is the time to implement changes that will make Canada more resilient to threats like this pandemic, writes Nav Persaud. The Hill Times photograph by Andrew Meade

Path to a stronger, more resilient Canada starts with equity

Opinion | BY NAV PERSAUD | December 28, 2021
  • COVID-19 will not take a break this holiday season, so we must remain focused on slowing its spread and on addressing the undercurrent that

Path to a stronger, more resilient Canada starts with equity

Opinion | BY NAV PERSAUD | December 28, 2021
  • COVID-19 will not take a break this holiday season, so we must remain focused on slowing its spread and on addressing the undercurrent that
While we focus on omicron’s rise, now is the time to implement changes that will make Canada more resilient to threats like this pandemic, writes Nav Persaud. The Hill Times photograph by Andrew Meade
More Stories

News

Get free news updates

Opinion

Submit a guest opinion article

resources

Advertise

get help

Subscribe
CloseMenu